Divi's Laboratories: The financial results for the period ended September 30, 2026

What happened

Divi's Laboratories (DIVISLAB) filed a disclosure with the exchanges on 7 November 2026 at 11:56 AM titled "The financial results for the period ended September 30, 2026".

Company snapshot

Divi's Laboratories is a large-cap company in the Healthcare sector, with a market value of about ₹2.74 lakh crore.

The stock last traded at ₹10,320.5, against a 52-week range of ₹5,647.5–₹10,159 (1.6% above the high).

Before this filing the shares had moved +6.2% over the month and +21.5% over three months. Average daily turnover over the last 20 sessions was about ₹626 crore.

Promoters held 51.88% at the end of Q1 FY27. Foreign institutions owned 20.20% and domestic institutions 19.38%.

What history shows

This is not the company's first results disclosure: BCEIE has 3 earlier filings of this kind on record since May 2026.

After those filings, the stock gained 1.0% on average the next trading day and was down 0.9% on average after five days (2 filings with price data).

Across 300 similar disclosures by other Healthcare companies, shares moved +1.5% on average the next day and +1.9% over five days; 58% of them rose the next day.

Market-wide, 10,949 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.

Past reactions describe what happened before; they are not a forecast.

What to watch

• Management commentary, margins and order book or guidance in the investor presentation.
• 7 November 2026: Board meeting — Financial Results.

Source

• Exchange filing (PDF)